IP Library › Granted Patent US 11,653,929
Granted Patent B2
US 11,653,929 · App. 16/761,051 · Granted May 23, 2023

Embolization catheter with integral filter

Inventors: Michael Gabriel Tal (Savyon, IL); Eran Miller (Moshav Beit Elazari, IL); Nir Holzman (Rishon LeZion, IL); Osnat Harbater (Raanana, IL); Yuval Zipory (Modiin, IL)
Assignee: ACCURATE MEDICAL THERAPEUTICS LTD.
A61B17/12186A61L29/049A61L29/085A61M25/005A61M25/007A61M25/0021A61B2017/1205A61M2025/0042A61M2025/0046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,653,929
App. No.
16/761,051
Granted
May 23, 2023
Kind
B2
Abstract

An embolization microcatheter is configured to deliver embolization particles to a target area and minimize or prevent embolization of a non-target area. The microcatheter includes a section, located between the distal and proximal ends of the microcatheter, having a skeleton formed of braided wires and a polymeric layer intercalated into and/or overlaying the skeleton. This section includes a plurality of axial slits, each slit having a smallest cross-sectional dimension configured to prevent outflow of the embolization particles.

Claims (25)

1. An embolization microcatheter for delivery of embolization particles to a target area, the microcatheter comprising:

a first section located at a proximal end of the microcatheter and configured for delivering the microcatheter to a target location;

a second section located at a distal end of the microcatheter and configured to restrict flow through the second section; the second section comprising a distal end opening sized and shaped to allow delivery of a suspension flowing through the microcatheter, the suspension comprising a suspension fluid and the embolization particles; and

a third section located between the first and the second sections; the third section comprising:

a skeleton formed of braided or coiled wires;

a polymeric layer, an outer surface and an inner surface; the polymeric layer intercalated into and/or overlaying the skeleton;

a plurality of axial slits formed proximal to and at a predetermined distance from the distal end opening, wherein each of the plurality of axial slits has a smallest cross-sectional dimension configured to prevent outflow of the embolization particles through each of the plurality of axial slits while allowing outflow of the suspension fluid through each of the plurality of axial slits, and wherein each of the plurality of axial slits extends from the outer surface of the third section to the inner surface of the third section, and wherein each of the plurality of slits has a larger width at the outer surface as compared to at the inner surface; and

wherein the plurality of slits are sized and shaped to allow a flow of the particles downstream of the third section at a volume flow rate which allows delivery of essentially all particles in the suspension through the distal end opening while preventing their backflow;

wherein each axial slit of the plurality of slits is spaced apart by 200-400 microns;

wherein the polymeric layer has an ultimate tensile strength of 2000-10000 psi and an ultimate elongation of 350-450%, and a Shore hardness of about 80A-90A;

wherein the third section is formed of a material having larger flexibility than the first section; wherein the embolization microcatheter has a tensile strength of at least about 5N, and wherein the third section has a kink-free radius of 0.5 mm-1.5 mm, while distortion of the axial slits is hindered.

2. The microcatheter of claim 1 , wherein the braided wires of the skeleton and the polymeric layer are cut, thereby forming the plurality of axial slits being essentially free of the skeleton and/or the polymeric layer.

3. The microcatheter of claim 2 , wherein the polymeric layer has an ultimate tensile strength of 9000-10000 psi.

4. The microcatheter of claim 3 , wherein the polymeric layer has an ultimate tensile strength of about 9600 psi and an ultimate elongation of approximately 400%.

5. The microcatheter of claim 2 , wherein the polymeric layer comprises a polycarbonate-based thermoplastic polyurethane.

6. The microcatheter of claim 1 , wherein the third section further comprises a hydrophilic coating overlaying the outer surface of the third section of the microcatheter, and wherein the plurality of axial slits are formed through the hydrophilic coating.

7. The microcatheter of claim 1 , wherein the third section further comprises an inner layer lining the inner surface of the third section of the microcatheter, wherein the plurality of axial slits is formed through the inner layer.

8. The microcatheter of claim 7 , wherein the inner layer comprises polytetrafluoroethylene (PTFE).

9. The microcatheter of claim 1 , wherein the first section has a flexural rigidity of about 0.003 to 0.01 lbs-in{circumflex over ( )}2.

10. The microcatheter of claim 1 , wherein the third section has a flexural rigidity of about 0.0001 to about 0.002 lbs-in{circumflex over ( )}2.

11. The microcatheter of claim 1 , wherein the second section has a tapered inner surface.

12. The microcatheter of claim 1 , wherein the second section has an inner lumen diameter in the range of about 0.2-0.75 mm.

13. The microcatheter of claim 1 , wherein a total open area of the plurality of slits of the third section is in the range of about 0.2-1 mm 2 .

14. The microcatheter of claim 1 , wherein a total open area of the plurality of slits of the third section is in the range of about 0.2-0.6 mm 2 .

15. The microcatheter of claim 1 , wherein at least 5-30% of the third section is open area formed by the plurality of slits.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2025
From: ACCURATE MEDICAL THERAPEUTICS LTD.
To: ARGON MEDICAL DEVICES, INC.
Reel/Frame 070704/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2020
From: TAL, GABRIEL MICHAEL; MILLER, ERAN; HOLZMAN, NIR; HARBATER, OSNAT; ZIPORY, YUVAL
To: ACCURATE MEDICAL THERAPEUTICS LTD.
Reel/Frame 052548/0856 →
Continuity (2)
Provisional Application 62580513 · Nov 2, 2017
Related Publication 20210177430A1 · Jun 17, 2021